(2004). Epidermal growth factor receptor (EGFR)-targeted immunoliposomes mediate specific and efficient drug delivery to EGFR- and EGFRvIII-overexpressing tumor cells. The Women's Oncology Review: Vol. 4, No. 2, pp. 99-101.
No takes yet. Share an insight, caveat, or question.
A 2004 study studied this question.